Skip to content
Other

Changes in estimates

Year-over-year, this metric was flat by 0.0%, from -$1M to -$1M. Over 4 years (FY 2021 to FY 2025), Changes in estimates shows an upward trend with a -24.0% CAGR.

Analysis

StatementCash Flow Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 28, 2026
Metric ID: other_restructuring_reserve_accrual_adjustment1

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$1M-$3M-$2M$0$0$0$0$0-$1M$0$0-$1M$0-$3M-$1M-$1M$0-$1M$0-$1M
QoQ Change-200.0%+33.3%+100.0%+100.0%+100.0%+66.7%+0.0%+100.0%+100.0%
YoY Change+100.0%+100.0%+100.0%+100.0%+0.0%+66.7%+100.0%+0.0%
Range-$3M$0
CAGR+0.0%
Avg YoY Growth+70.8%
Median YoY Growth+100.0%
Current Streak6+ quarters growth

Frequently Asked Questions

What is Xylem's changes in estimates?
Xylem (XYL) reported changes in estimates of -$1M in Q1 2026.
How has Xylem's changes in estimates changed year-over-year?
Xylem's changes in estimates decreased by 0.0% year-over-year, from -$1M to -$1M.
What is the long-term trend for Xylem's changes in estimates?
Over 4 years (2021 to 2025), Xylem's changes in estimates has grown at a -24.0% compound annual growth rate (CAGR), from -$6M to -$2M.